MOORE JOHN R (General Counsel) sold 17.0% of their position (2.10K shares) of EDGEWISE THERAPEUTICS, INC. on the open market
Open‑market sale worth $28.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/14/2025ACC: 0001562180-25-005799
Officer· General Counsel
Since Mar 2021
+186.03K
Net shares
Net buyer
$28.1K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
193.91K acquired · 7.88K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5.78K
Price / share
—
Trade value
—
% of position
88.5%
8/12/2025
6.53K→12.31K
Common Stock
Direct
Shares
−2.10K
Price / share
$13.39
Trade value
$28.10K
% of position
17.0%
8/12/2025
12.31K→10.21K
Total
Net shares
+3.68K
Net value
-$28.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2025 | M · Option Exercise | +5.78K | — | — | 88.5% | 6.53K | 12.31K |
| Common Stock Direct | 8/12/2025 | S · Sale | −2.10K | $13.39 | $28.10K | 17.0% | 12.31K | 10.21K |
| Total | +3.68K | -$28.10K | ||||||
Derivative Transactions3
Restricted Stock Units
Direct
Converts to
Common Stock
5.78K shares
Shares
−5.78K
Strike price
0.00
Held after
17.34K
Exercisable
—
8/12/2025
Restricted Stock Units
Direct
Converts to
Common Stock
26.88K shares
Shares
+26.88K
Strike price
0.00
Held after
26.88K
Exercisable
—
8/12/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
161.25K shares
Shares
+161.25K
Strike price
13.39
Held after
161.25K
Exercisable
—
8/12/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5.78K shares | 8/12/2025 | M · Option Exercise | −5.78K | 0.00 | — | 17.34K |
| Restricted Stock Units Direct | Common Stock26.88K shares | 8/12/2025 | A · Award | +26.88K | 0.00 | — | 26.88K |
| Stock Option (Right to Buy) Direct | Common Stock161.25K shares | 8/12/2025 | A · Award | +161.25K | 13.39 | — | 161.25K |